Single-step Placenta Accreta Resective Technique Tourniqueted vs Absence, Conservative Uterine Surgery

Launched by CAIRO UNIVERSITY · Dec 15, 2023

Keywords

ClinConnect Summary

This clinical trial is studying two different methods for treating a condition called placenta accreta, which occurs when the placenta grows too deeply into the uterine wall. The trial aims to find out if using a tourniquet—a device that can temporarily stop blood flow—during surgery makes the procedure safer and more effective compared to not using one. It involves 40 pregnant women who have had previous cesarean deliveries and meet certain health criteria. They will be divided into two groups: one where the tourniquet is used during surgery and one where it is not.

To be eligible for this trial, participants need to be pregnant women with a confirmed diagnosis of placenta accreta and should be at least 34 weeks along in their pregnancy. They should also desire to keep their uterus for future pregnancies. However, women over 40 or those with certain medical conditions or severe bleeding will not be included. If you participate, you can expect careful monitoring and support throughout the surgery and recovery process, and your contribution will help improve surgical techniques for this challenging condition.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pregnant females with previous CS deliveries (at least 1).
• • Patients with ultrasound criteria of placenta accerta spectrum.
• • Patients desiring fertility (uterine conservation).
• • Patients with gestational age that completed 34 weeks (or more) confirmed by the 1st day of the LMP or 1st trimester ultrasound scan.
• Exclusion Criteria:
• • Maternal age above 40 years.
• • Chronic medical disorders (e.g., cardiac, renal, DM and hepatic diseases).
• • Patients presented with severe antepartum hemorrhage (unstable vital signs).
• • Patients requested radical management (caesarean hysterectomy).